LogoLogoLogoLogoLogo
  • Portfolio
  • News
    • In the News
    • Press Releases
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us
  • Portfolio
  • News
    • In the News
    • Press Releases
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Circulating Tumor Cell, Cell Free DNA and Exosome/Microvesicle Cancer Diagnostics

...

GRAIL Details Plans for Early Cancer Detection Trials, Products

VC-backed GRAIL Appoints Cook as CEO

Early Cancer Detection Startup GRAIL Closes on $900 Million in Series B Funding

LinkedIn Top Companies: The 50 Most Sought-after Startups

Early Cancer-Detection Startup GRAIL is Reportedly Trying to Raise More Money

PARP Inhibitor May Be Effective Against Some TNBC-Lacking BRCA Mutations

How Science is Unlocking the Cancer Medicines of the Future

Genomic Medicine Has Entered the Building

Healthcare is Looking to the Tech World for Recruitment

  • 1
  • 2
  • 3
  • 4
  • 5
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104
USA

Contact Us
Cookie Settings

 

In the News

  • Aster Insights Announces Presentations at SITC’s 38th Annual Meeting

  • Blue Cross Blue Shield of Michigan Launches Comprehensive Cancer Support Program

  • City of Hope and Reimagine Care Collaborate to Offer 24/7 Monitoring and Support to Bone Marrow Transplant Patients

  • Inbound Health Secures $30 Million in Funding Led by HealthQuest Capital to Accelerate Growth of At-Home Advanced Care Programs

Subscribe to Updates via Email

Enter your email address to subscribe to McKesson Ventures updates.

©2021 McKesson Ventures | Privacy Notice | Disclaimer
@McK_Ventures
McKesson Ventures LinkedIn